Dr. Alenghat's laboratory focuses on macrophage biology and the inflammatory processes underlying atherosclerosis. His clinical and academic interests span cardiovascular physiology and pathophysiology, with a particular emphasis on vascular biology and the role of inflammatory pathways in the development of atherosclerotic disease. In addition, Dr. Alenghat has expertise in integrin biology, mechanotransduction, and extracellular matrix biology.
His research aims to uncover fundamental mechanisms that regulate cardiovascular health and disease. A central project in his laboratory investigates how a signaling pathway activated downstream of integrins in macrophages influences atherogenesis and macrophage polarization. The lab employs a range of techniques, including mouse husbandry, tissue sample preparation, immunohistochemistry, and quantitative confocal microscopy.
Dr. Alenghat is also deeply committed to mentoring future physicians and scientists, with a broader goal of promoting health through a deeper understanding of and reduction in cardiovascular disease.
            Harvard College
                        S.B. - Engineering
                      
            Harvard Graduate School of Arts & Sciences
                        Ph.D. - Biophysics
                      
            Harvard Medical School
                        M.D. - Medicine
                      
            Brigham & Women's Hospital
                         - Internal Medicine
                      
            Brigham & Women's Hospital
                         - Cardiovascular Medicine
                      
            Management of Atrial Fibrillation.
            Management of Atrial Fibrillation. JAMA. 2024 Dec 10; 332(22):1936-1937.
            PMID: 39541112
          
            Improved Prognostic Performance of Cardiac Power Output With Right Atrial Pressure: A Subanalysis of the ESCAPE Trial.
            Improved Prognostic Performance of Cardiac Power Output With Right Atrial Pressure: A Subanalysis of the ESCAPE Trial. J Card Fail. 2022 05; 28(5):866-869.
            PMID: 34774746
          
            The impact of lipid-lowering medications on coronary artery plaque characteristics.
            The impact of lipid-lowering medications on coronary artery plaque characteristics. Am J Prev Cardiol. 2021 Dec; 8:100294.
            PMID: 34877559
          
            ATTR Cardiomyopathy Meets Multiple Myeloma: The Importance of Cardiac Biopsy.
            ATTR Cardiomyopathy Meets Multiple Myeloma: The Importance of Cardiac Biopsy. JACC CardioOncol. 2021 Oct; 3(4):598-601.
            PMID: 34729534
          
            A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction.
            A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction. ESC Heart Fail. 2021 10; 8(5):3495-3503.
            PMID: 34369088
          
            Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram.
            Rapid Exclusion of COVID Infection With the Artificial Intelligence Electrocardiogram. Mayo Clin Proc. 2021 08; 96(8):2081-2094.
            PMID: 34353468
          
            Comparison of semi-automated versus manual quantitative right ventricular assessment in tetralogy of Fallot.
            Comparison of semi-automated versus manual quantitative right ventricular assessment in tetralogy of Fallot. Cardiol Young. 2021 Nov; 31(11):1781-1787.
            PMID: 33685532
          
            Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial.
            Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial. ESC Heart Fail. 2021 04; 8(2):1522-1530.
            PMID: 33595923
          
            Donor-derived cell-free DNA is associated with cardiac allograft vasculopathy.
            Donor-derived cell-free DNA is associated with cardiac allograft vasculopathy. Clin Transplant. 2021 03; 35(3):e14206.
            PMID: 33368611
          
            Donor derived cell free DNA is Associated with Cardiac Allograft Vasculopathy.
            Holzhauser L, Clerkin KJ, Fujino T, Alenghat FJ, Raikhelkar J, Kim G, Sayer G, Uriel N. Donor derived cell free DNA is Associated with Cardiac Allograft Vasculopathy. Clin Transplant. 2020 Dec 25; e14206.
            PMID: 33368611
          
            Fellow of the American College of Cardiology (FACC)
            American College of Cardiology
            2017          
            ATVB Young Investigator Travel Award
            Council on Arteriosclerosis, Thrombosis, and Vascular Biology
            2015          
            William F. Keating Award for Hypertension & Peripheral Vascular Disease
            American College of Cardiology
            2013          
            Thomas W. Smith Fellowship 
            Brigham & Women's Hospital
            2012          
            AHA/ATVB Travel Award for Young Investigators
            American Heart Association
            2011          
            Future Leaders in CV Medical Research Award
            Leadership Council for Improving Cardiovascular Care 
            2010          
            Laennec Young Clinician Award Finalist
            American Heart Association
            2009          
            James Tolbert Shipley Prize
            Harvard Medical School
            2005          
            Howard Hughes Predoctoral Fellowship
            Howard Hughes Medical Institute
            1999          
            Tau Beta Pi for Excellence in Engineering
            Harvard College
            1997          
            Phi Beta Kappa
            Harvard College
            1996          
            Detur Prize
            Harvard College
            1994          
